Study
Bacopa monnieri May Support Cognitive Health in Seniors
A study explores how the herb Bacopa monnieri might help maintain cognitive function and support healthy aging in older adults.
Brain HealthMemory SupportHealthy AgingHerbal Remedies
Summary
In plain language
Recent research is looking into the potential benefits of Bacopa monnieri, a traditional herb, in helping older adults maintain cognitive health. The study focuses on whether this herb can influence aging processes and support brain function. Participants will take a Bacopa monnieri supplement for 45 days, with researchers assessing its effects on cellular aging and mental ability. While the results are still forthcoming, this study could lead to new ways of supporting cognitive health in seniors, aligning with both traditional and modern approaches. Remember, it's always a good idea to talk to your healthcare provider before starting any new supplement.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study is a clinical trial examining the effects of Bacopa monnieri on aging and cognitive function in healthy older adults. Participants are divided into two groups: one receiving the herb supplement and the other a placebo. The trial will assess changes in cellular aging markers and cognitive abilities.
The study uses a controlled trial design, with 74 participants aged 60-64, to test the herb's impact on brain health.
Researchers will measure telomere length and telomerase activity, indicators of cellular aging, alongside cognitive tests.
While promising, it's important to note that the study is still ongoing, and more evidence is needed to confirm these potential benefits.
Seniors interested in this approach should discuss it with their healthcare providers to ensure it's suitable for them.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Peer-reviewed publication · RCT
Bacopa monnieri May Support Cognitive Health in Seniors
Published January 2026 · DOI 10.3389/fmed.2026.1702773
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
The study scores well in design and transparency due to its RCT nature and detailed methodology. However, the open-label design limits bias control. Statistical integrity is strong with pre-specified endpoints and power calculations. The absence of journal information affects the journal quality score. The study is relevant to the target population, and conflicts of interest are transparently managed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 10.0/10 | |
| Bias & Methods | 3.3/10 | |
| Statistical Integrity | 10.0/10 | |
| Transparency | 10.0/10 | |
| Conflict of Interest Disclosure | 10.0/10 | |
| Replication / External Validation | 0.0/10 | |
| Relevance to Seniors | 10.0/10 | |
| Journal Quality | 0.0/10 |
Additional Notes
This RCT evaluates the effects of Bacopa monnieri on cognitive health and aging markers in healthy older adults. It measures telomere length, telomerase activity, and neurocognitive functions over a 45-day intervention period.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.